Osocimab for VTE Prevention After TKA, Changes in FDA Approval and Regulation of Pharmaceuticals, Neuropsych Testing of Older Clinicians Prior to Recredentialing, and more

JAMA Editor’s Summary

Osocimab for VTE Prevention After TKA, Changes in FDA Approval and Regulation of Pharmaceuticals, Neuropsych Testing of Older Clinicians Prior to Recredentialing, and more

Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the January 14, 2020 issue

January 14, 2020

Listen on your favorite player Take me to this show’s page

Newer →

HES vs Saline for Volume Replacement in High-Risk Surgery, Early Surgery vs Endoscopy for Chronic Pancreatitis, Catheter Ablation with vs without Renal Denervation in Atrial Fibrillation, and more

← Older

Effect of Folic Acid and Zinc on Semen Quality and Infertility Outcomes, Genital Talc Use and Ovarian Cancer, Fostering Physician Presence and Connection With Patients, and more

Facebook Twitter Buffer LinkedIn WhatsApp

Osocimab for VTE Prevention After TKA, Changes in FDA Approval and Regulation of Pharmaceuticals, Neuropsych Testing of Older Clinicians Prior to Recredentialing, and more

Editor’s Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the January 14, 2020 issue

Listen on your favorite player

New to Podcasts? It's easy to get started!

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Join Our Newsletter

We gratefully acknowledge the many organizations that have generously supported our podcasts and platform.

Network Sponsors and Advertisers

Event and Media Partners

00:00

00:00